SLC2A1 and neoplasm: Tumor suppressor miR-1291-5p could act as a metabolism regulator and potentiate the sensitivity to DDP via diminishing glucose transporter protein type 1 (GLUT1) expression and GLUT1-mediated glycolysis in ASPC-1 and PANC-1 PC cells (Tu et al., 2020).